C
Cambiotics
Probiotic for PFAS forever chemicals
About Cambiotics
Cambiotics develops precision probiotics designed to support the body’s natural removal of PFAS (“forever chemicals”). Its lead product concept 46& combines probiotic strains (including Bacteroides and Streptococcus lineages such as 46-XY1 and 46-SL1) selected for their ability to bioaccumulate PFAS in the gut so they can be excreted rather than reabsorbed.
Public science origins include University of Cambridge research showing certain gut bacteria absorb PFAS; Cambiotics is translating that into dietary-supplement / Novel Food pathways with planned human studies (including high-exposure groups such as firefighters). Messaging emphasizes long-chain PFAS that rely on fecal excretion and non-GMO, non-AMR strains.
Cambiotics sells / will sell consumer and clinical probiotic supplements for PFAS reduction. The business model is biotech / dietary supplement commercialization of microbiome science.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2024
- Headquarters
- Copenhagen, Denmark
- Employees
- 11
- Open positions
- None listed
- Dealroom signal
- 78.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, Woman Founder, PFAS, DT and LS, UKSU, UKSU2010, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Feb 2026 | $4.4M | $18M | True. · Export and Investment Fund of Denmark · Collaborative Fund | ↗ |
| SPINOUT✓Other financing | Jan 2024 | $0 | — | University of Cambridge | — |
Growth signals
Latest recorded traffic for Cambiotics is 3.2K monthly website visits, down 3% over the last three months. Cambiotics's team grew 57.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Collaborative Fund
True.
Export and Investment Fund of Denmark
Other known investors2 additional known investors
University of Cambridge
BioInnovation Institute
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cambiotics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cambiotics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.